Does a Rescue Course of Betamethasone in Pregnant Women With PPROM Decrease Neonatal Morbidity?
Status:
Recruiting
Trial end date:
2023-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if a repeat course of betamethasone given to
pregnant women with preterm premature rupture of membranes (PPROM) will decrease the infant's
length of stay in the neonatal intensive care unit (NICU) and the overall neonatal morbidity
associated with this condition.